|

Apixaban 2.5 milligram Oral Tablet Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Region Stockholm1

Indications

  • Thromboses, Venous1
  • Major Bleed1
  • Heart Disease1
  • Intracerebral Hemorrhage1
  • Kidney Transplant; Complications1

Other1 trial

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.